视网膜、脉络膜及玻璃体等疾病诊治研究

The diagnosis and treatment of retinal, choroid and vitreous diseases

北京大学医学部眼科学博士；5848vip威尼斯电子游戏附属同济医院临床研究中心主任；上海市医学会眼科分会眼底病学组委员；上海市医学会医学科研管理分会委员；上海市医学会生物医药转化分会委员；上海市医院协会临床研究管理分会委员。

M.D. of Ophthalmology, Peking University Health Science Center; Director of Clinical Research Unit, Tongji Hospital of Tongji University; Member of fundus disease Group, Ophthalmology Branch of Shanghai Medical Association; Member of the ninth Committee of Medical Research Management Branch of Shanghai Medical Association; Member of the first Committee of Biomedical Transformation Branch of Shanghai Medical Association; Member of the first Committee of Clinical Research Management Branch, Shanghai Hospital Association.

主持国家自然科学基金1项、上海市卫健委面上项目5项、上海申康中心科研项目4项、上海市医院协会科研项目1项，参与上海市科委、上海市卫健委、申康、上海市科协等科研项目10余项；以第一作者或通讯作者在国内外期刊发表论文20余篇（其中SCI 8篇，中华系列7篇），重点为增殖性玻璃体视网膜病变、脉络膜新生血管方向。获软件著作权3项。主持获2021中国医院管理奖科技创新组银奖，主持获第十一期上海市“星光计划”一等奖。获5848vip威尼斯电子游戏教学成果奖一等奖（7/10）。

Presided as principal investigator over one National Natural Science Foundation Project , five Shanghai Municipal Health Bureau Project and four Shanghai Hospital Development Center Project respectively. Participated as major researcher on several Projects. Published more than 20 papers as the first author or corresponding author, focusing on proliferative vitreoretinopathy and choroidal neovascularization. Presided over the 2021 China Hospital Management Award Science and Technology Innovation Group silver Award. Presided over the 11th Shanghai "Star Program" first prize. Won the first prize of Tongji University Teaching Achievement Award (7/10).